Skip to content

A Strategic Approach to

Public & Investor Relations

At HLTH Communications, we believe that clear, strategic communication is vital for building trust and fostering strong relationships. Our expert team crafts tailored public and investor relations strategies that resonate with your audience, ensuring your brand’s message is impactful and engaging. Whether you’re in biotech, neuroscience, mental health, psychedelics, or longevity, we help you navigate complex landscapes and achieve your goals through effective and thoughtful communication.

Amplify your story, ignite your success

At HLTH Communications, we specialize in transforming your unique story into powerful narratives that resonate and inspire. Our strategic approach leverages media relations, thought leadership, and innovative content strategies to amplify your brand’s presence and impact. By aligning your message with your audience’s values and interests, we help you ignite success, drive engagement, and achieve measurable business outcomes. Let us help you turn your vision into a compelling story that captivates and delivers results.

Our Services

Designed to meet the diverse needs of our clients

Thought Leadership

Developing and promoting expert insights positions you as a leader in your field, leveraging executive commentary, bylined articles, and speaking opportunities.

Investor Relations

Build and maintain strong investor relationships through transparent communication strategies that highlight financial performance and strategic vision.

Content Strategy & Design

Compelling content creation includes brand strategy, creative writing, immersive digital experiences, and visual storytelling that resonate with your audience.

Media Relations

Achieve targeted media coverage by aligning your messaging with trends and establishing credibility through strategic campaigns.

Social Media

Engage investor communities with data-driven social media strategies that amplify your message and enhance your online presence.

Events

Ensure high engagement and seamless delivery with flawlessly planned and executed events, from large-scale conferences to intimate exhibitions.

Areas of Focus

We've helped leading brands across industries achieve measurable growth and market leadership

Biotech

We provide strategic communications for biotech companies, ensuring their groundbreaking innovations receive the attention they deserve.

Neuropsychiatry

Our expertise in neuropsychiatric communications helps companies in this field effectively convey complex medical information.

Neuroscience

Our firm supports neuroscience companies by creating compelling narratives that explain their research and breakthroughs.

Mining

We deliver strategic communications for mining companies, helping them spotlight resource potential, navigate regulatory milestones, and attract investor interest at every stage—from exploration to production.

Mental Health

We specialize in promoting mental health initiatives and organizations, using strategic communications to raise awareness and reduce stigma.

Psychedelics

We help psychedelic research and therapy companies communicate their innovative approaches and scientific findings.

Longevity

Our communications expertise in the longevity sector focuses on promoting advancements in life extension and healthy aging.

The Results

The numbers speak for themselves

$40M+

Raised for Clients

3x

Dominance in industry conversations within 6 months

65%

Average client year-over-year growth

Download Our e-Book

Discover the Secrets to Successful Communication

Unveil the key to transforming public and investor relations in the healthcare and biotech industries. This eBook is your guide to mastering crisis communication, engaging the media, and aligning financial narratives with public storytelling. Featuring actionable checklists and real-world case studies, it’s a must-read for professionals looking to elevate their communication strategies.

Client Case Studies

Learn How We Did It

With Wonderland Conference, our mission was to amplify the event’s reach and impact, capturing the attention of diverse audiences and stakeholders through a targeted PR campaign and media partnerships.
MindBio Therapeutics partnered with us to promote their groundbreaking clinical trials in psychedelic microdosing, aiming to transform mental health treatment.
Enveric Biosciences focuses on developing cutting-edge neuroplastogenic small-molecule therapeutics to treat neuropsychiatric disorders. By leveraging their proprietary discovery platform, The Psybrary™, Enveric aims to transform mental health treatment.

Our Clients Have Been Featured In

Founders Led

Meet Our Team

Natalie Dolphin

🇨🇦 Toronto, Canada

Natalie Dolphin has over 15 years of experience in marketing, business development, and capital markets. She has a proven track record in raising capital, having secured $40M+ USD for clients, and excels in driving business growth and securing investment opportunites.

Play Video

Mentions in the Press

Celebrating Our Clients' success

Enveric Hires Fish & Richardson To Defend IP Against Petition Claiming Its Patent Contains Claims Relevant To AbbVie’s $1.2B Bretisilocin Acquisition

Enveric Biosciences (NASDAQ:ENVB) recently announced that it has hired intellectual property powerhouse Fish and Richardson P.C. to contest a Post-Grant Review (PGR) petition filed by rival Gilgamesh Pharmaceuticals against Enveric’s issued U.S. Patent No. 12,138,276 (the ‘276 patent) titled, “Halogenated psilocybin derivatives and methods of using.”

Read Now

The Quiet Race Reshaping Psychedelic Medicine

For years, the psychedelic renaissance focused on one clear idea. If you could deliver a guided psychedelic experience safely and predictably, you could lift people out of stubborn depression, trauma, and addiction. That wave brought psilocybin, MDMA, ketamine clinics, and a flood of research interest. However, it was not adoptable by large patient bases.

Read Now

Healing A Broken Mental Health System: Dr Joseph Tucker of Enveric Biosciences On 5 Things That Can Be Done To Fix Our Broken Mental Health System

Focus on prevention and early intervention, especially in youth. Modernize reimbursement models to reward outcomes, not volume. Invest more in innovative therapies that offer rapid, durable symptom relief. Investment is focused on low risk, late stage therapies, but what is needed to really make a difference is the higher risk innovative ideas. Rebuild trust and […]

Read Now

Delix Therapeutics Reports Strong Phase Ib Results

Delix Therapeutics recently announced compelling data from a Phase Ib trial of DLX-001 (zalsupindole), a non-hallucinogenic neuroplastogen. According to the company’s release, DLX-001 produced robust biomarker signals (quantitative EEG and polysomnography) consistent with engagement of neuroplasticity pathways, while delivering rapid and durable antidepressant effects in adults with major depressive disorder (MDD).

Read Now

The Strategy That Could Help US Decouple From China’s Rare Earths

Boarded-up mines across the world are rusting symbols of how China seized the world’s critical minerals supply chain. Now, some of these mines—closed not because they ran dry, but by Beijing’s oversupply and price dumping—could be reopened as the Trump administration rallies nations to overthrow China’s supply chain dominance.

Read Now

Startup Revolution: Natalie Dolphin of HLTH Communications On How Their Emerging Startup Clients are Changing the Game

Thank you! My journey to founding HLTH Communications wasn’t a straight line. It was more much more like a zigzag that eventually pointed to a clear purpose. I began my career in capital markets, working a boutique investment bank and later working with private as well as public companies raise capital, go public and help […]

Read Now

06/08/2025

|

21 min

The Business of Hlth Podcast

Listen to the latest episode of our podcast

The Business of HLTH podcast, a HLTH Communications Production, provides an in-depth look at the evolving health sector. We interview investors and innovators, exploring the latest in health tech, longevity and biotech investments, uncovering where capital is moving. Join us for insights into the future of health.

How we will work with you

Our Process

1 Research

Our initial focus will be on examining your past actions to determine what has been effective and what hasn’t. We’ll also delve into understanding your target audience, collecting essential messages and materials, and clarifying your objectives. Additionally, we’ll analyze your competitors’ marketing strategies to identify successful approaches.

2 Implementation

Following the research phase, we’ll develop and align a Media Relations program with your broader marketing strategy. This will involve setting up your press office and brainstorming pitch ideas.

3 Pitch Pitch Pitch

Through meticulous planning, organization, and interaction with journalists, we aim to secure high-quality coverage for you. This will contribute significantly to building a positive and robust media presence, which will be highly valued by your customers and search engines like Google.

4 Evaluation

You’ll have real-time access to information about our pitch efforts, ongoing conversations with targeted journalists, and all metrics related to secured coverage.

Testimonials

Hear from Happy Customers

What I love most about working with HLTH Communications is how they confidently present their client’s expertise and convey the value it will bring to our readership. And they’re spot on. In addition to being dedicated client advocates, the team knows how to work well with journalists by being prompt, thorough, and cordial through every interaction — pitch to publication.
Abby Proch
Executive Director, Clinical Leader
HLTH Communications launched Equulus Therapeutics out of “Stealth Mode” and we went from being unknown to being a widely recognized neuroscience startup biotech virtually overnight. Their capabilities and contacts in the PR space provided us high visibility to the right companies at the right time to allow us to achieve the next critical steps in our company’s journey.
Bob Discordia
CEO, Equulus Therapeutics
HLTH is a dedicated, conscientious public relations firm that goes above and beyond to help journalists. Working with them is simple and I like their no nonsense, can-do attitude. I look forward to working with them again.
Mattha Louis Busby
Journalist
Working with Natalie and Kristina at HLTH is like working with your best friends who understand you, always be there for you and advocate for you with real passion! They are also trusted advisors that you can rely on for expert opinion on branding and PR issues. HLTH's professionalism, industry reach and hardwork is an integral part of PurMinds' growth and success!
Janet Qi, CPA, MBA
CEO, PurMinds Neuropharma
It has been a real pleasure working with HLTH Communications over the last few months. They make my life much easier as a journalist when I am looking to talk to relevant experts in the life sciences industry, reaching out to me with source suggestions perfectly suited to each individual topic I am writing about. Their professionalism and media relation skills are second to none and I can always count on them to provide a swift response and collect detailed answers from suggested sources in plenty of time before my proposed deadlines.
Willow Shah-Neville
Reporter Labiotech.eu

Take Your First Steps

Are you ready to elevate your brand?

Explore how we can help you achieve your goals and drive tangible business results.